|
BY92917 |
(E)-ethyl 3-(3-((1-allyl-2,5-dioxoimidazolidin-4-ylidene)methyl)-2,5-dimethyl-1H-pyrrol-1-yl)benzoate |
593274-87-4 |
C22H23N3O4 |
393.4357 |
VIEW DETAILS > |
|
BW04037 |
(5Z)-5-[[1-(3,4-dichlorophenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-prop-2-enylimidazolidine-2,4-dione |
593274-88-5 |
C19H17Cl2N3O2 |
390.2632 |
VIEW DETAILS > |
|
BS65337 |
(5E)-5-[[1-(2-chlorophenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-prop-2-enylimidazolidine-2,4-dione |
593274-89-6 |
C19H18ClN3O2 |
355.8181 |
VIEW DETAILS > |
|
BV90868 |
(E)-ethyl 2-(2-bromo-4-((2,5-dioxoimidazolidin-4-ylidene)methyl)-6-methoxyphenoxy)acetate |
593274-90-9 |
C15H15BrN2O6 |
399.1934 |
VIEW DETAILS > |
|
BY12518 |
2-[[5-bromo-4-[(E)-(2,5-dioxoimidazolidin-4-ylidene)methyl]-2-methoxyphenoxy]methyl]benzonitrile |
593274-91-0 |
C19H14BrN3O4 |
428.2362 |
VIEW DETAILS > |
|
BV57951 |
(5Z)-3-[(2-chlorophenyl)methyl]-5-[(2-methyl-4-pyrrolidin-1-ylphenyl)methylidene]imidazolidine-2,4-dione |
593274-92-1 |
C22H22ClN3O2 |
395.8820 |
VIEW DETAILS > |
|
BT02198 |
4-[5-[(E)-[1-[(4-methylphenyl)methyl]-2,5-dioxoimidazolidin-4-ylidene]methyl]furan-2-yl]benzonitrile |
593274-93-2 |
C23H17N3O3 |
383.3994 |
VIEW DETAILS > |
|
BW31734 |
(5Z)-3-[(4-bromophenyl)methyl]-5-[[5-(3-nitrophenyl)furan-2-yl]methylidene]imidazolidine-2,4-dione |
593274-94-3 |
C21H14BrN3O5 |
468.2570 |
VIEW DETAILS > |
|
BV20873 |
ethyl 2-[3-[(Z)-[1-[(4-bromophenyl)methyl]-2,5-dioxoimidazolidin-4-ylidene]methyl]indol-1-yl]acetate |
593274-95-4 |
C23H20BrN3O4 |
482.3266 |
VIEW DETAILS > |
|
AG69092 |
Integrin Antagonist 27 |
593274-97-6 |
C24H20N4O5 |
444.4394 |
VIEW DETAILS > |